Correlation Between GlaxoSmithKline PLC and TLGY Acquisition
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and TLGY Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and TLGY Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and TLGY Acquisition Corp, you can compare the effects of market volatilities on GlaxoSmithKline PLC and TLGY Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of TLGY Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and TLGY Acquisition.
Diversification Opportunities for GlaxoSmithKline PLC and TLGY Acquisition
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between GlaxoSmithKline and TLGY is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and TLGY Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TLGY Acquisition Corp and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with TLGY Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TLGY Acquisition Corp has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and TLGY Acquisition go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and TLGY Acquisition
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 5.76 times less return on investment than TLGY Acquisition. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.01 times less risky than TLGY Acquisition. It trades about 0.0 of its potential returns per unit of risk. TLGY Acquisition Corp is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,086 in TLGY Acquisition Corp on August 26, 2024 and sell it today you would earn a total of 69.00 from holding TLGY Acquisition Corp or generate 6.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. TLGY Acquisition Corp
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| TLGY Acquisition Corp |
GlaxoSmithKline PLC and TLGY Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and TLGY Acquisition
The main advantage of trading using opposite GlaxoSmithKline PLC and TLGY Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, TLGY Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TLGY Acquisition will offset losses from the drop in TLGY Acquisition's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |